FRMM on Nasdaq
FORUM MARKETS Inc
FORUM MARKETS Inc is a finance services company based in Palm Beach, listed on Nasdaq (FRMM).1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Financial Gravity Companies, Inc., BitMine Immersion or Qudian, or pick any stock.
- TickerFRMM on Nasdaq1
- IndustryFinance Services1
- HeadquartersPalm Beach, Florida1
- Business address2875 South Ocean Blvd, Suite 200, Palm Beach, Fl2
- Filer categoryNon-accelerated filer, Smaller reporting company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
RWAs into compliant, tradable instruments with both primary and secondary market liquidity.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Liquid Staking Revenue brought in 91% of the revenue FORUM MARKETS Inc broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2025 |
|---|---|
| Liquid Staking Revenue | $6.0M |
| Native Staking Revenue | $455.0K |
| Reward Revenue | $141.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs100¢$6.5M
Out of $6.5M in revenue.5 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $6.5M | |
| Total Revenue | $6.5M | |
| General and administrative | $240.0M | $4.4M |
| Total Operating Expenses | $240.0M | $4.4M |
| Loss From Operations | -$233.4M | -$4.4M |
| Dividend income | $1.2M | |
| Interest income | $4.5M | |
| Other income | $1.8M | |
| Interest expense | -$3.1M | -$35.0K |
| Change in fair value of convertible debt | -$103.9M | |
| Change in fair value of available for sale securities | -$138.0K | |
| Digital asset gains and losses | -$21.1M | |
| Change in fair value of long-term receivable derivative | -$81.3M | |
| Loss on make whole provision | -$6.3M | |
| Gain on settlement of liabilities | $53.0K | |
| Total other (expense) income, net | -$210.1M | $1.8M |
| Loss Before Income Taxes | -$443.5M | -$2.6M |
| Income tax expense (benefit) | -$2.0K | |
| Net Loss From Continuing Operations | -$443.5M | -$2.6M |
| Net Loss From Discontinued Operations | -$7.0M | -$3.6M |
| Deemed dividend | -$8.0M | |
| Net Loss | -$450.5M | -$14.2M |
| Foreign currency translation adjustments | -$114.0K | -$16.0K |
| Change in fair value of held to maturity securities | $38.0K | |
| Total other comprehensive income (loss) | -$76.0K | -$16.0K |
| Total Comprehensive Loss | -$450.6M | -$14.2M |
| Continuing operations, basic (in Dollars per share) | -$54 | -$29 |
| Continuing operations, diluted (in Dollars per share) | -$54 | -$29 |
| Discontinued operations, basic (in Dollars per share) | -$1 | -$39 |
| Discontinued operations, diluted (in Dollars per share) | -$1 | -$39 |
| Basic (in Shares) | 8.2M shares | 91.5K shares |
| Diluted (in Shares) | 8.2M shares | 91.5K shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $8.0M | $4.6M | |
| Restricted cash equivalents | $1.0M | ||
| Prepaid expenses and other current assets | $4.5M | $478.0K | |
| Current assets of discontinued operations | $22.0K | $97.0K | |
| Total Current Assets | $13.6M | $5.1M | |
| Marketable securities | $4.4M | ||
| Non-marketable securities | $45.7M | ||
| Digital assets | $61.6M | ||
| Staking receivables | $181.0M | ||
| Other assets of discontinued operations | $7.6M | ||
| Total Assets | $306.3M | $12.8M | |
| Accounts payable | $1.5M | $306.0K | |
| Accrued expenses | $6.4M | $304.0K | |
| Loans payable current portion | $251.0K | $1.0K | |
| Collateralized loan current portion | $31.5M | ||
| Current liabilities of discontinued operations | $1.2M | $2.8M | |
| Total Current Liabilities | $40.9M | $3.5M | |
| Collateralized loan non current | $25.9M | ||
| Long term liabilities of discontinued operations | $7.0K | ||
| Total Liabilities | $66.9M | $3.5M | |
| Common stock, $0.0001 par value; 5,000,000,000 shares authorized; 19,012,231 and 317,705 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $2.0K | ||
| Additional paid-in capital | $834.5M | $153.7M | |
| Accumulated other comprehensive income | -$3.0M | -$2.9M | |
| Accumulated deficit | -$592.0M | -$141.5M | |
| Total Stockholders Equity | $239.4M | $9.3M | -$127.0K |
| Total Liabilities and Stockholders Equity | $306.3M | $12.8M | |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in Shares) | 5.0M shares | 5.0M shares | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 5.0B shares | 5.0B shares | |
| Common stock, shares issued (in Shares) | 19.0M shares | 317.7K shares | |
| Common stock, shares outstanding (in Shares) | 19.0M shares | 317.7K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $8.0M | $4.6M | |
| Restricted cash equivalents | $1.0M | ||
| Prepaid expenses and other current assets | $4.5M | $478.0K | |
| Current assets of discontinued operations | $22.0K | $97.0K | |
| Total Current Assets | $13.6M | $5.1M | |
| Marketable securities | $4.4M | ||
| Non-marketable securities | $45.7M | ||
| Digital assets | $61.6M | ||
| Staking receivables | $181.0M | ||
| Other assets of discontinued operations | $7.6M | ||
| Total Assets | $306.3M | $12.8M | |
| Accounts payable | $1.5M | $306.0K | |
| Accrued expenses | $6.4M | $304.0K | |
| Loans payable current portion | $251.0K | $1.0K | |
| Collateralized loan current portion | $31.5M | ||
| Current liabilities of discontinued operations | $1.2M | $2.8M | |
| Total Current Liabilities | $40.9M | $3.5M | |
| Collateralized loan non current | $25.9M | ||
| Long term liabilities of discontinued operations | $7.0K | ||
| Total Liabilities | $66.9M | $3.5M | |
| Common stock, $0.0001 par value; 5,000,000,000 shares authorized; 19,012,231 and 317,705 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $2.0K | ||
| Additional paid-in capital | $834.5M | $153.7M | |
| Accumulated other comprehensive income | -$3.0M | -$2.9M | |
| Accumulated deficit | -$592.0M | -$141.5M | |
| Total Stockholders Equity | $239.4M | $9.3M | -$127.0K |
| Total Liabilities and Stockholders Equity | $306.3M | $12.8M | |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in Shares) | 5.0M shares | 5.0M shares | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 5.0B shares | 5.0B shares | |
| Common stock, shares issued (in Shares) | 19.0M shares | 317.7K shares | |
| Common stock, shares outstanding (in Shares) | 19.0M shares | 317.7K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss from continuing operations | -$443.5M | -$2.6M |
| Stock-based compensation | $213.4M | $280.0K |
| Change in fair value of long-term receivable derivative | $81.3M | |
| Change in fair value of cryptocurrency | $21.1M | |
| Change in fair value of available for sale securities | $138.0K | |
| Change in fair value of convertible debt | $103.9M | |
| Non-cash staking and incentive revenue | -$6.5M | |
| Loss on make whole provision | $6.3M | |
| Gain on settlement of liabilities | -$53.0K | |
| Prepaid expenses and other current assets | -$3.3M | $1.3M |
| Accounts payable | $1.4M | -$200.0K |
| Accounts payable - related parties | -$36.0K | $51.0K |
| Accrued expenses | $500.0K | $94.0K |
| Total adjustments | $418.2M | $1.5M |
| Net cash used in operating activities from continuing operations | -$25.3M | -$1.1M |
| Net cash used in operating activities from discontinued operations | -$758.0K | -$24.0K |
| Net cash used in operating activities | -$26.1M | -$1.2M |
| Purchases of marketable securities | -$4.6M | |
| Purchases of digital assets | -$244.3M | |
| Purchase of non-marketable securities | -$13.0M | |
| Sale of digital asset | $134.3M | |
| Net cash used in investing activities from continuing operations | -$127.6M | |
| Net cash used in investing activities | -$127.6M | |
| Proceeds from sale of December 2024 Offering stock and warrants | $2.6M | |
| Repayment of loans payable | -$364.0K | -$1.3M |
| Repayment of loans payable related parties | -$1.0M | |
| Treasury stock purchases | -$46.3M | |
| Proceeds from collateralized loan | $50.0M | |
| Repayment of collateralized loan | -$50.0M | |
| Proceeds from convertible debt, net | $500.0M | |
| Repayment of convertible debt, net | -$603.9M | |
| Proceeds from exercise of common stock options | $455.0K | |
| Proceeds from exercise of common stock warrants | $5.6M | $2.8M |
| Proceeds from shares issued for cash and warrants, net | $303.8M | |
| Net cash provided by financing activities from continuing operations | $158.3M | $4.1M |
| Net cash used in financing activities from discontinued operations | -$151.0K | -$33.0K |
| Net cash provided by financing activities | $158.2M | $4.0M |
| Net Change In Cash, cash equivalents and restricted cash equivalents | $4.5M | $2.9M |
| Cash paid during the period for interest expense | $12.0K | |
| Shares issued for settlement of liabilities | $751.0K | $685.0K |
| Prepaid expense financed with notes payable | $722.0K | $778.0K |
| Loan proceeds received in cryptocurrency | $57.2M | |
| Warrants and Series B Convertible Preferred Stock issued for asset acquisition | $7.6M | |
| ETH holdings contributed in exchange for common stock | $171.3M | |
| Deposits into liquid staking protocols (i.e., staking receivables) | $260.1M | |
| Deemed dividend from warrant inducement | $8.0M | |
| Shares issued for non-marketable securities | $32.7M |
No quarter-by-quarter statement was filed.
Corporate structure
FORUM MARKETS Inc sits at the top of its group. 18 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of FORUM MARKETS Inc
- Citadel Cyber Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Aug 14, 2026 (2 filings since Oct 1, 2025)
- Electric Capital Partners Frontier Master Fund, LP Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Aug 14, 2026 (2 filings since Oct 2, 2025)
- Zippy, Inc. /DE Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Aug 14, 2026 (2 filings since Dec 15, 2025)
- Brian James Pemble Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Jul 7, 2026 (3 filings since Oct 15, 2025)
- Citadel Securities GP LLC Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Feb 17, 2026 (2 filings since Sep 25, 2025)
- FF Consumer Growth II, LP Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Feb 17, 2026 (3 filings since Aug 11, 2025)
- Hudson Bay Capital Management LP Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Feb 9, 2026 (2 filings since Nov 12, 2025)
- STEADFAST CAPITAL MANAGEMENT LP Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Nov 14, 2025 (2 filings since Aug 12, 2025)
- Anthony Brian Goodman Filed SCHEDULE 13D/A on FORUM MARKETS Inc, latest Aug 18, 2025 (2 filings since Jan 10, 2025)
- Blair Jordan Filed SCHEDULE 13D/A on FORUM MARKETS Inc, latest Aug 6, 2025 (5 filings since Feb 25, 2025)
- AmTrust Financial Services, Inc. Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest Jul 22, 2025 (2 filings since Apr 16, 2025)
- Anson Funds Management LP Filed SCHEDULE 13G/A on FORUM MARKETS Inc, latest May 15, 2025 (2 filings since Feb 14, 2025)
- FORUM MARKETS Inc Palm Beach, Florida
- 180 Life Corp. Subsidiary · Delaware, United States
- 180 Therapeutics LP Subsidiary · Delaware, United States
- CannBioRex Callco ULC Subsidiary · British Columbia, Canada
- CannBioRex Pharma Limited Subsidiary · United Kingdom
- CannBioRex Pharmaceuticals Corp. Subsidiary · British Columbia, Canada
- CannBioRex Purchaseco ULC Subsidiary · British Columbia, Canada
- ETHZilla Aerospace, LLC Subsidiary · Nevada, United States
- ETHZilla Auto Loans, LLC Subsidiary · Florida, United States
- ETHZilla Group, LLC Subsidiary · Florida, United States
- ETHZilla Holdings, LLC Subsidiary · Florida, United States
- ETHZilla Modular Mortgage, LLC Subsidiary · Florida, United States
- Eurus Aerospace Token I, LLC Subsidiary · Delaware, United States
- Karus Token I, LLC Subsidiary · Delaware, United States
- Katexco Callco ULC Subsidiary · British Columbia, Canada
- Katexco Pharmaceuticals Corp. Subsidiary · British Columbia, Canada
- Katexco Purchaseco ULC Subsidiary · British Columbia, Canada
- Zippy Token I, LLC Subsidiary · Delaware, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What FORUM MARKETS Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $8.0M5 Dec 31, 2025 | $2.1M6 Dec 31, 2020 | +280.3% |
| Marketable securities, current | $4.4M5 Dec 31, 2025 | ||
| Marketable securities, non-current | $4.4M5 Dec 31, 2025 | ||
| Deposits held (banks) | $262.3M5 Dec 31, 2025 |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $7.6M5 Dec 31, 2024 | $1.6M10 Dec 31, 2023 | +370.6% |
| Finite-lived intangibles, gross | $9.8M10 Dec 31, 2024 | $2.2M10 Dec 31, 2023 | +351.4% |
| Accumulated amortization | $611.8K10 Dec 31, 2024 | $542.9K10 Dec 31, 2023 | +12.7% |
Properties, in its own words
On March 27, 2026, the Company, through its wholly-owned subsidiary, Eurus Aerospace, acquired one CFM International model CFM56-5B5/P aircraft engine, together with all parts, engine records and engine stands associated therewith, from Aero Engine Solutions, Inc., pursuant to the terms of an Engine Sale and Purchase Agreement dated March 27, 2026. The Engine was acquired for $6.35 million, which was payable in cash.
Eurus Aerospace entered into certain Lease Agreements with a major airline, as lessee, following the acquisition of the Engine, to evidence the lease of such Engine to that airline.
The rest of Item 2
The Company also entered into a Service Agreement Supplement with the Servicer in connection with the purchase, whereby the Servicer agreed to manage the Engine on behalf of the Company during the duration of the above referenced leases, in exchange for a monthly servicing fee, and also provided for the right of the Company (but not the obligation) to require the Servicer (or the Servicer’s designated affiliate) to purchase the Engine from the Company for a $3.0 million option price, following the expiration or earlier termination of the leases with respect to such Engine; and the right of the Servicer (but not the obligation) to require the Company to sell the Engine to the Servicer (or the Servicer’s designated affiliate) for $3.0 million, following the expiration or earlier termination of the leases with respect to such Engine, in each case provided that such Engine is in the condition required by the terms of the agreement.
Item 2 of the 10-K filed Apr 1, 2026.4
Leadership
Who has led FORUM MARKETS Inc, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerBlair Jordan Feb 7, 2025 to Nov 17, 202513
- Chief executive officerMcAndrew Rudisill Nov 17, 2025 to now14
- Chief executive officerJames N. Woody Nov 12, 2020 to Dec 18, 202315
- Chief executive officerMarlene Krauss Jun 1, 2017 to Jun 27, 201716
- Chief financial officerJohn Tazewell Saunders Dec 3, 2025 to now17
- Chief financial officerOzan Pamir Dec 7, 2020 to Sep 6, 202318
- Chief operating officerQuan Anh Vu Nov 4, 2021 to Dec 16, 202119
- Chief operating officerJoseph Williamson Jun 1, 2017 to Jun 1, 201720
Board members and other officers (25)
- Chief Accounting OfficerLent Eric R. Van Feb 24, 2025 to now21
- Chief Scientific OfficerJonathan B. Rothbard Nov 25, 2020 to Sep 8, 202322
- Board memberAngela Dalton Apr 6, 2026 to now23
- Board memberAndrew P. Suckling Aug 7, 2025 to now24
- Board memberMcAndrew Rudisill Aug 7, 2025 to now25
- Board memberCrystal Jane Heter Aug 12, 2025 to now26
- Board memberJason Griffin New Nov 14, 2025 to now27
- Board memberOmar Jimenez Mar 11, 2024 to Mar 11, 202428
- Board memberRyan Lewis Smith Mar 11, 2024 to now29
- Board memberBlair Jordan Mar 12, 2024 to now30
- Board memberJay Lawrence Goodman Oct 29, 2024 to now31
- Board memberKnuettel Francis Ii. Jul 6, 2021 to Sep 8, 202332
- Board memberPamela G. Marrone Jul 7, 2021 to Sep 6, 202333
- Board memberRussell T. Ray Jul 12, 2021 to Sep 8, 202334
- Board memberTeresa Deluca Jul 13, 2021 to Sep 8, 202335
- Board memberDonald A. McGovern Jr. Nov 12, 2020 to Sep 6, 202336
- Board memberJames N. Woody Nov 12, 2020 to Dec 18, 202315
- Board memberLawrence Gold Nov 12, 2020 to Sep 6, 202337
- Board memberLawrence Steinman Nov 12, 2020 to now38
- Board memberShoshana Shendelman Nov 13, 2020 to Nov 13, 202039
- Board memberMarc Feldmann Nov 18, 2020 to Dec 28, 202340
- Board memberRichard W. Barker Nov 25, 2020 to Dec 7, 202041
- Board memberJoseph Williamson Jun 1, 2017 to Jun 1, 201720
- Board memberMarlene Krauss Jun 1, 2017 to Jun 27, 201716
- Board memberP. Sherrill Neff Jun 1, 2017 to Jun 1, 201742
Named in SEC Form D filings
People the company listed in its private-offering notices.
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- 180 Life Corp. Delaware3
- 180 Therapeutics LP Delaware3
- CannBioRex Callco ULC British Columbia3
- CannBioRex Pharma Limited United Kingdom3
- CannBioRex Pharmaceuticals Corp. British Columbia3
- CannBioRex Purchaseco ULC British Columbia3
- ETHZilla Aerospace, LLC Nevada3
- ETHZilla Auto Loans, LLC Florida3
- ETHZilla Group, LLC Florida3
- ETHZilla Holdings, LLC Florida3
- ETHZilla Modular Mortgage, LLC Florida3
- Eurus Aerospace Token I, LLC Delaware3
- Karus Token I, LLC Delaware3
- Katexco Callco ULC British Columbia3
- Katexco Pharmaceuticals Corp. British Columbia3
- Katexco Purchaseco ULC British Columbia3
- Zippy Token I, LLC Delaware3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
Timeline
- Oct 5, 20268-K Entered a material agreement; New debt or obligation; Unregistered sale of shares44
- Aug 21, 20268-K Executive or director change45
- Aug 19, 20268-K Shareholder vote46
- Jul 30, 20268-K Entered a material agreement47
- Jul 16, 20268-K Entered a material agreement; Regulation FD disclosure48
- Jul 1, 20268-K Entered a material agreement49
- Jun 30, 20268-K Other events50
- May 14, 20268-K Results of operations51
- Apr 29, 20268-K Regulation FD disclosure52
- Apr 24, 20268-K Change to shareholders' rights; Bylaws or fiscal year changed53
- Apr 17, 20268-K Regulation FD disclosure; Other events54
- Apr 8, 20268-K Entered a material agreement55
- Nov 17, 2025New chief executive McAndrew Rudisill becomes CEO14
- Feb 7, 2025New chief executive Blair Jordan becomes CEO13
- Nov 12, 2020New chief executive James N. Woody becomes CEO15
- Jun 1, 2017New chief executive Marlene Krauss becomes CEO16
Calendar
Coming up
- Nov 13, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($16.80) a share, on Nov 14, 2025.56
When it reported results
- May 14, 2026Reported quarterly or annual results51
- Mar 31, 2026Reported quarterly or annual results57
- Nov 14, 2025Reported quarterly or annual results58
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
499 filings to the SEC since October 2021: 10 annual reports, 15 quarterly reports, 161 major events, 129 insider forms, 41 large holders, 2 private raises, 141 other. The latest 20:
- Oct 5, 20268-K CURRENT REPORT EDGAR
- Aug 21, 20268-K CURRENT REPORT EDGAR
- Aug 19, 20268-K CURRENT REPORT EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 14, 20264 EDGAR
- Aug 14, 202610-Q QUARTERLY REPORT EDGAR
- Aug 14, 20264 EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Jul 30, 20268-K CURRENT REPORT EDGAR
- Jul 23, 20264 PRIMARY DOCUMENT EDGAR
- Jul 20, 20264 PRIMARY DOCUMENT EDGAR
- Jul 16, 20268-K CURRENT REPORT EDGAR
- Jul 14, 20264 EDGAR
- Jul 9, 20264 EDGAR
- Jul 9, 2026DEFA14A SOLICITING MATERIAL PURSUANT TO 240.14A-12 EDGAR
- Jul 9, 2026ARS EDGAR
- Jul 8, 2026DEF 14A DEFINITIVE PROXY STATEMENT EDGAR
- Jul 7, 2026SCHEDULE 13G/A EDGAR
- Jul 7, 20263 EDGAR
The 499 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
27 open-market trades by officers, directors and large owners since October 2021: 17 buys and 10 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Lomashuk Konstantin10% owner | Sale | 250,000 | $6.00 | $1.5M | Form 4 |
| Jul 15, 2026 | Lomashuk Konstantin10% owner | Sale | 2,562 | $6.30 | $16.1K | Form 4 |
| Jul 9, 2026 | Lomashuk Konstantin10% owner | Sale | 3,387 | $6.15 | $20.8K | Form 4 |
| Jul 8, 2026 | Lomashuk Konstantin10% owner | Sale | 1,100 | $6.13 | $6.7K | Form 4 |
| Jul 7, 2026 | Lomashuk Konstantin10% owner | Sale | 3,702 | $6.41 | $23.7K | Form 4 |
| Aug 11, 2025 | ELRAY RESOURCES, INC. | Sale | 405,148 | $3.17 | $1.3M | Form 4 |
| Aug 8, 2025 | ELRAY RESOURCES, INC. | Sale | 777,595 | $3.18 | $2.5M | Form 4 |
| Aug 7, 2025 | ELRAY RESOURCES, INC. | Sale | 135,257 | $3.56 | $481.5K | Form 4 |
| Jul 27, 2025 | ELRAY RESOURCES, INC. | Sale | 1,680,000 | $3.00 | $5.0M | Form 4 |
| Dec 15, 2023 | Feldmann MarcDirector | Sale | 25,000 | $0.19 | $4.8K | Form 4 |
| Dec 15, 2023 | Woody James N.Chief Executive Officer | Buy | 25,000 | $0.19 | $4.8K | Form 4 |
| Jun 1, 2023 | STEINMAN LAWRENCEDirector | Buy | 18,000 | $1.23 | $22.1K | Form 4 |
| May 31, 2023 | McGovern Jr. Donald A.Director | Buy | 10,000 | $1.15 | $11.5K | Form 4 |
| May 19, 2023 | McGovern Jr. Donald A.Director | Buy | 5,000 | $1.16 | $5.8K | Form 4 |
| May 18, 2023 | McGovern Jr. Donald A.Director | Buy | 10,000 | $1.05 | $10.5K | Form 4 |
| May 18, 2023 | Marrone Pamela GDirector | Buy | 7,082 | $1.06 | $7.5K | Form 4 |
| May 18, 2023 | Pamir OzanCFO | Buy | 5,162 | $1.01 | $5.2K | Form 4 |
| May 18, 2023 | Woody James N.Chief Executive Officer | Buy | 40,000 | $1.03 | $41.2K | Form 4 |
| Dec 16, 2021 | Vu Quan AnhCOO / Chief Business Officer | Buy | 8,000 | $3.98 | $31.8K | Form 4 |
| Dec 10, 2021 | Pamir OzanCFO | Buy | 3,800 | $3.87 | $14.7K | Form 4 |
All 27 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Citadel CyberSCHEDULE 13G/A, 2 filings Oct 1, 2025 to Aug 14, 202659
- Electric Capital Partners Frontier Master Fund, LPSCHEDULE 13G/A, 2 filings Oct 2, 2025 to Aug 14, 202660
- Zippy, Inc. /DESCHEDULE 13G/A, 2 filings Dec 15, 2025 to Aug 14, 202661
- Brian James PembleSCHEDULE 13G/A, 3 filings Oct 15, 2025 to Jul 7, 202662
- Citadel Securities GP LLCSCHEDULE 13G/A, 2 filings Sep 25, 2025 to Feb 17, 202663
- FF Consumer Growth II, LPSCHEDULE 13G/A, 3 filings Aug 11, 2025 to Feb 17, 202664
- Hudson Bay Capital Management LPSCHEDULE 13G/A, 2 filings Nov 12, 2025 to Feb 9, 202665
- STEADFAST CAPITAL MANAGEMENT LPSCHEDULE 13G/A, 2 filings Aug 12, 2025 to Nov 14, 202566
- Anthony Brian GoodmanSCHEDULE 13D/A, 2 filings Jan 10, 2025 to Aug 18, 202567
- Blair JordanSCHEDULE 13D/A, 5 filings Feb 25, 2025 to Aug 6, 202568
- AmTrust Financial Services, Inc.SCHEDULE 13G/A, 2 filings Apr 16, 2025 to Jul 22, 202569
- Anson Funds Management LPSCHEDULE 13G/A, 2 filings Feb 14, 2025 to May 15, 202570
- Ayrton Capital LLCSCHEDULE 13G/A, 2 filings Feb 13, 2025 to May 14, 202571
- ELRAY RESOURCES, INC.SCHEDULE 13D/A, 1 filing Apr 11, 202572
- INTRACOASTAL CAPITAL, LLCSCHEDULE 13G, 1 filing Jan 3, 202573
- ARMISTICE CAPITAL, LLCSC 13G/A, 2 filings Feb 14, 2024 to Nov 14, 202474
- Marc FeldmannSC 13G, 3 filings Dec 13, 2021 to Oct 18, 202475
- VANGUARD GROUP INCSC 13G/A, 1 filing Feb 9, 202276
- VANGUARD INDEX FUNDSSC 13G/A, 1 filing Feb 9, 202277
- Jagdeep NanchahalSC 13G/A, 1 filing Feb 7, 202278
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | McAndrew Rudisill | 47 | $200.0K | $20.3M79 |
| 2025 | Blair Jordan | $190.6K | $16.8M79 | |
| 2025 | John Saunders | 44 | $154.7K | $2.0M79 |
| 2025 | Eric Van Lent | $142.0K | $221.9K79 | |
| 2024 | Former CEO | $140.1K79 |
Money raised
Private offerings the company reported to the SEC on Form D.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 39. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Stokes Family Office, LLC | 958,275 | $5.2M | 0.6% | +190,475 |
| Vise Technologies, Inc. | 857,141 | $4.7M | 0.1% | New |
| Citadel Advisors LLC | 413,552 | $2.2M | 0.0% | +68,327 |
| Saba Capital Management, L.P. | 371,561 | $2.0M | 0.1% | −109,148 |
| Vanguard Capital Management LLC | 302,063 | $1.6M | 0.0% | +117,676 |
| BlackRock, Inc. | 301,339 | $1.6M | 0.0% | +48,913 |
| Geode Capital Management, LLC | 179,977 | $977.7K | 0.0% | −23,656 |
| UBS Group AG | 169,656 | $921.2K | 0.0% | −158,138 |
| Goldman Sachs Group Inc | 167,047 | $907.1K | 0.0% | +5,292 |
| Morgan Stanley | 144,535 | $784.8K | 0.0% | −7,108 |
| Bank Of America Corp /de/ | 124,358 | $675.3K | 0.0% | +30,000 |
| Barclays PLC | 97,265 | $528.1K | 0.0% | +1,183 |
| Almitas Capital LLC | 80,408 | $436.6K | 0.1% | No change |
| Millennium Management LLC | 77,772 | $422.3K | 0.0% | +5,427 |
| State Street Corp | 76,221 | $413.9K | 0.0% | +15,169 |
| Vanguard Fiduciary Trust Co | 71,410 | $387.8K | 0.0% | −8,639 |
| Group One Trading LLC | 68,200 | $370.3K | 0.0% | +34,579 |
| Charles Schwab Investment Management Inc | 64,766 | $351.7K | 0.0% | −4,234 |
| Wealthspire Advisors, LLC | 56,653 | $307.6K | 0.0% | New |
| Jane Street Group, LLC | 56,286 | $305.6K | 0.0% | −55,566 |
| ExodusPoint Capital Management, LP | 56,016 | $304.2K | 0.0% | −39,475 |
| Invesco Ltd. | 31,069 | $168.7K | 0.0% | −21,728 |
| Northern Trust Corp | 29,106 | $158.0K | 0.0% | −4,168 |
| J. Derek Lewis & Associates Inc. | 22,100 | $120.0K | 0.0% | −6,900 |
| IMC-Chicago, LLC | 15,778 | $85.7K | 0.0% | −23,664 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How FORUM MARKETS Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARFORUM MARKETS Inc1
- CIK0001690080
- Employer ID (EIN)90-18903544
- LEI98450063A2D8EF54EB111
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inDelaware4
- Fiscal year endsDecember 311
- Industry code (SIC)6199 Finance Services1
- SEC reviewing officeOffice of Crypto Assets, Division of Corporation Finance1
- Business address2875 South Ocean Blvd, Suite 200, Palm Beach, FL1
- Phone561-486-81981
- Shares outstanding13,198,948 as of Aug 14, 202612
- Public float$2.7M as of Jun 30, 20254
- AuditorM&K CPAS, PLLC, Woodlands, TX PCAOB ID 2738; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceNov 16, 20161
- Filings761 in all: 8-K (207), 4 (141), 3 (40), CORRESP (30), 10-Q (28), 424B3 (25), UPLOAD (20), EFFECT (19)1
All 50 form types
SC 13G (17), DEF 14A (16), SC 13G/A (16), SCHEDULE 13G/A (13), PRE 14A (12), SCHEDULE 13G (12), 4/A (11), S-1/A (11), DEFA14A (10), POS AM (10), 10-K (9), S-1 (9), 425 (8), 8-K/A (7), S-8 (7), 424B4 (6), 424B5 (6), NT 10-Q (6), SCHEDULE 13D/A (6), 10-K/A (5), 144 (5), D (4), NT 10-K (4), S-3 (4), S-3ASR (4), SC 13D/A (4), ARS (3), AW (3), POSASR (3), 10-Q/A (2), 25-NSE (2), DRS/A (2), DRSLTR (2), S-4/A (2), SC 13D (2), SCHEDULE 13D (2), 3/A (1), 8-A12B (1), CERTNAS (1), DRS (1), RW (1), S-4 (1)
- Latest filingsAnnual report (10-K) Apr 1, 2026
Quarterly report (10-Q) Aug 14, 2026
Proxy statement (DEF 14A) Jul 8, 2026
Latest 8-K (8-K) Oct 5, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.0001 per share | FRMM | The Nasdaq Stock Market LLC |
From the cover page of the 10-K filed Apr 1, 2026 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks FORUM MARKETS Inc names in Item 1A of its 10-K filed Apr 1, 2026: 32 risks under these headings, as written.4
- Risks Related to Holding Digital Assets and Our Tokenization Strategies
- Our business strategy has a limited operating history and volatility in the price of our tokenized securities could materially and adversely affect our financial results and the market price of our common stock.
- We face risks relating to the custody of our Digital Assets, including concentration with one or more custodians, limits on insurance coverage, and adverse outcomes in insolvency proceedings.
- If we were deemed to be an investment company under the Investment Company Act, applicable restrictions likely would make it impractical for us to continue our business as currently conducted.
- Volatility in the price of our tokenized securities could materially adversely affect our financial results and the market price of our common stock.
- Regulatory uncertainty regarding ETH, our digital assets treasury strategy and our tokenization activities could subject us to additional regulation, enforcement actions and significant compliance costs, require us to materially change or cease certain operations, and adversely affect the market price of ETH and our securities.
- We are dependent on third parties and third-party platforms to execute and support the trading and transfer of our tokenized securities
- We rely on third-party service providers to support “know-your-customer” and AML investor verification for our tokenized securities, and any failure or interruption of those services could disrupt our tokenization activities.
- We may rely on smart contracts that are upgradeable, which could introduce operational, security, and governance risks and could adversely affect our tokenization activities.
- If the Company fails to commercialize its plans to securitize RWAs and allow such RWAs to be monetized through tokenized tradable instruments with both primary and secondary market liquidity, in the future, the Company could once again be deemed to be a “shell company.”
- We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisers.
- Our ETH holdings are concentrated and less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents.
The other 21 risks
- Our digital asset holdings expose us to risk of non-performance by providers and counterparties.
- Our common stock may be more volatile and may trade at a substantial premium or discount to the value of the digital assets we hold.
- The availability of spot exchange-traded products (“ETPs”) for ETH and other digital assets may adversely affect the market price of ETH or other digital assets and, consequently, the trading price of our common stock.
- Changes in the accounting treatment of our ETH holdings and the application of fair value accounting could materially increase the volatility of our results and adversely affect the market price of our common stock.
- Transactions using ETH require the payment of “gas fees,” which are subject to fluctuations that may result in high transaction fees.
- Liquid staking applications pose risks associated with concentration of control.
- Lending arrangements may expose us to risks of borrower default and operational failures.
- Security breaches or cyberattacks could result in loss of our digital assets and disrupt our tokenization activities.
- Risks Related to our Common Stock
- The price of our common stock has and may continue to fluctuate significantly.
- Resales of our common stock in the public market by our stockholders, or the perception that such sales may occur, may cause the market price of our shares of common stock to fall.
- Our stock repurchases are discretionary and even if effected, they may not achieve the desired objectives.
- Sales of our common stock through our ATM Program, or the perception that such sales may occur, could cause the market price of our common stock to fall.
- You may experience future dilution as a result of future equity or debt offerings.
- We have never paid dividends on our common stock, and we do not anticipate paying any cash dividends in the foreseeable future.
- General Risks
- If we make acquisitions, they may disrupt or have a negative impact on our business.
- Our limited number of employees subjects us to significant resource constraints, which may hinder our ability to comply with public company regulations and manage our operations effectively.
- We have in the past, and may in the future, identify material weaknesses in our disclosure controls and procedures and internal control over financial reporting. If not remediated, our failure to establish and maintain effective disclosure controls and procedures and internal control over financial reporting could result in material misstatements in our financial statements and a failure to meet our reporting and financial obligations, each of which could have a material adverse effect on our financial condition and the trading price of our common stock.
- Our classified Board of Directors structure may delay or complicate changes in control of our Board of Directors, but a hostile takeover or activist campaign could nevertheless result in changes to our Board of Directors and management that adversely affect our business and the market price of our common stock.
- Changes in applicable tax laws and regulations could adversely affect our business.
- Our tax burden could increase as a result of ongoing or future tax audits.
- Taxation of digital assets is complex and evolving.
Legal proceedings
From time to time, we may be a party to litigation that arises in the ordinary course of our business.
Such current litigation or other legal proceedings are described in, and incorporated by reference in this “Item 3. Legal Proceedings,” from Note 14 – Commitments and Contingencies–Litigation and Other Loss Contingencies to our Consolidated Financial Statements included in this Report. The Company believes that the resolution of currently pending matters will not individually or in the aggregate have a material adverse effect on our financial condition or results of operations. However, assessment of the current litigation or other legal claims could change in light of the discovery of facts not presently known to the Company or by judges, juries or other finders of fact, which are not in accord with management’s evaluation of the possible liability or outcome of such litigation or claims.
Additionally, the outcome of litigation is inherently uncertain. If one or more legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s financial condition and operating results for that reporting period could be materially adversely affected.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGAROzan Pamir, Chief financial officer
- 19SEC EDGARQuan Anh Vu, Chief operating officer
- 20
- 21
- 22
- 23SEC EDGARAngela Dalton, Board member
- 24SEC EDGARAndrew P. Suckling, Board member
- 25SEC EDGARMcAndrew Rudisill, Board member
- 26SEC EDGARCrystal Jane Heter, Board member
- 27SEC EDGARJason Griffin New, Board member
- 28SEC EDGAROmar Jimenez, Board member
- 29SEC EDGARRyan Lewis Smith, Board member
- 30SEC EDGARBlair Jordan, Board member
- 31SEC EDGARJay Lawrence Goodman, Board member
- 32SEC EDGARKnuettel Francis Ii., Board member
- 33SEC EDGARPamela G. Marrone, Board member
- 34SEC EDGARRussell T. Ray, Board member
- 35SEC EDGARTeresa Deluca, Board member
- 36SEC EDGARDonald A. McGovern Jr., Board member
- 37SEC EDGARLawrence Gold, Board member
- 38SEC EDGARLawrence Steinman, Board member
- 39SEC EDGARShoshana Shendelman, Board member
- 40SEC EDGARMarc Feldmann, Board member
- 41SEC EDGARRichard W. Barker, Board member
- 42SEC EDGARP. Sherrill Neff, Board member
- 43
- 44
- 45SEC EDGARExecutive or director change
- 46SEC EDGARShareholder vote
- 47SEC EDGAREntered a material agreement
- 48
- 49SEC EDGAREntered a material agreement
- 50SEC EDGAROther events
- 51SEC EDGARResults of operations
- 52SEC EDGARRegulation FD disclosure
- 53
- 54
- 55SEC EDGAREntered a material agreement
- 56NasdaqNasdaq calendar
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79